Evidence map›Paper›PMID 17420766›Full record

ArticleMolecular psychiatry2007

Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity.

E Sibille, J Su, S Leman, A M Le Guisquet, Y Ibarguen-Vargas, J Joeyen-Waldorf, C Glorioso, G C Tseng, M Pezzone, R Hen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Age effects on serotonin receptor 1B as assessed by PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2012
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Aerobic training as a means to enhance inhibition: what's yet to be studied?European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2015
    Article
  14. Hypothalamic control of sleep in aging.Neuromolecular medicine · 2012
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. A lifespan view of anxiety disorders.Dialogues in clinical neuroscience · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

E SibilleDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA 15213, USA. sibilleel@upmc.edu
J Su
S Leman
A M Le Guisquet
Y Ibarguen-Vargas
J Joeyen-Waldorf
C Glorioso
G C Tseng
M Pezzone
R Hen
C Belzung
University of Pittsburgh · USUniversité de Tours · FRColumbia University · USUniversity of Pittsburgh Medical Center · US

Funding

Transcriptome analysis in major depressionR01MH077159 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCCLUNG, COLLEEN A, SIBILLE, ETIENNE L · 2007 to 2015
$3.2M
Genomic Characterization in Depression and Suicide.K01MH067721 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIBILLE, ETIENNE L · 2003 to 2007
$793k
Molecular characterization of a corticolimbic network in depressionK02MH084060 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIBILLE, ETIENNE L · 2009 to 2013
$589k
NIMH NIH HHS K01 MH067721NIMH NIH HHS K02 MH084060NIMH NIH HHS R01 MH077159
6 · The paper itself

Abstract

Normal aging of the brain differs from pathological conditions and is associated with increased risk for psychiatric and neurological disorders. In addition to its role in the etiology and treatment of mood disorders, altered serotonin (5-HT) signaling is considered a contributing factor to aging; however, no causative role has been identified in aging. We hypothesized that a deregulation of the 5-HT system would reveal its contribution to age-related processes and investigated behavioral and molecular changes throughout adult life in mice lacking the regulatory presynaptic 5-HT(1B) receptor (5-HT(1B)R), a candidate gene for 5-HT-mediated age-related functions. We show that the lack of 5-HT(1B)R (Htr1b(KO) mice) induced an early age-related motor decline and resulted in decreased longevity. Analysis of life-long transcriptome changes revealed an early and global shift of the gene expression signature of aging in the brain of Htr1b(KO) mice. Moreover, molecular changes reached an apparent maximum effect at 18-months in Htr1b(KO) mice, corresponding to the onset of early death in that group. A comparative analysis with our previous characterization of aging in the human brain revealed a phylogenetic conservation of age-effect from mice to humans, and confirmed the early onset of molecular aging in Htr1b(KO) mice. Potential mechanisms appear independent of known central mechanisms (Bdnf, inflammation), but may include interactions with previously identified age-related systems (IGF-1, sirtuins). In summary, our findings suggest that the onset of age-related events can be influenced by altered 5-HT function, thus identifying 5-HT as a modulator of brain aging, and suggesting age-related consequences to chronic manipulation of 5-HT.

Indexed as

Age FactorsAgingAnalysis of VarianceAnimalsAnimals, NewbornBehavior, AnimalDopamine Plasma Membrane Transport ProteinsEnzyme-Linked Immunosorbent AssayGene ExpressionGene Expression RegulationHand StrengthIn Situ HybridizationMaze LearningMiceMice, KnockoutMicroarray AnalysisDopamine Plasma Membrane Transport ProteinsReceptor, Serotonin, 5-HT1B

Identifiers

PMID17420766
PMCPMC2515886
OpenAlexW2169940916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.